Probing the biophysical regulation of metastasis - AcCelerator L1
Closed Special Notice Posted
- Solicitation number
- 75N91020P00517-97
- Agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Place of performance
- Bethesda MD 20892 USA
Notice details come from SAM.gov. Updated .
Notice text
The U.S. Department of Health and Human Services (DHHS), National Institutes of Health (NIH), National Cancer Institute (NCI), Center for Cancer Research (CCR), Lab of Cell Biology (LCB), Office of Acquisitions (OA) plans to procure, on a sole source a basis, a synchronized high-power illumination AcCellerator L1 from ZELLMECHANIK DRESDEN GmbH located at Tatzberg 47/49, 01307 Dresden, Germany
The response close date of this notice for this requirement is in accordance with FAR 5.203(a)(1). This acquisition will be processed under FAR Part 12 – Acquisition for Commercial Items and will be made pursuant to the authority in FAR 13.106-1(b)(1) using simplified acquisition procedures for commercial acquisitions and is exempt from the requirements of FAR Part 6. The North American Industry Classification System code is 541714 – Research and Development in Biotechnology (except Nanobiotechnology).
It has been determined there are no opportunities to acquire green products or services for this procurement.
Files
| File | Type | Posted |
|---|---|---|
| (AcCellerator L1)-Special Notice-(Final)-(6-15-2020).pdf | ||
| (AcCellerator L1)-Special Notice-(Final)-(6-15-2020).docx | DOCX document |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity